Christopher Migliaccio, Ph.D., Pharm.D., the IPHARM Clinical Specialist for the project. Chris received his Ph.D. in Immunology from the University of California, Davis in 2000 and his Pharmacy Doctorate from the University of Montana in 2016. Upon graduation from UM he was awarded the Excellence in Public Health Pharmacy from the United States Public Health Service. In addition to being research faculty in the School of Pharmacy since 2008, he is the Director of the Inhalation and Pulmonary Physiology Core facility in the Center for Environmental Health Science in the School of Pharmacy. His interests in respiratory health extend to asthma education, exposures to wood smoke, nanoparticles exposures, and vaccinations. He has published more than twenty journal articles and chapters on immunology and respiratory research and was awarded a grant from the American Lung Association for work on the effects of wood smoke exposure to respiratory immunity. He currently serves on the editorial board for Inhalation Toxicology.
Donna G. Beall, Pharm.D., BCPS, the Project Coordinator for the IPHARM project. Dr. Beall is a Professor, Department of Pharmacy Practice, and Clinical Pharmacy Specialist at the Curry Health Center at The University of Montana. She received her B.S. in Pharmacy from Northeastern University in Boston, Massachusetts, and Doctor of Pharmacy degree from The University of Florida. Dr. Beall has worked in many ambulatory/managed care environments. These positions include being employed as a clinical pharmacy specialist at the Veteran's Affairs Medical Center in Gainesville, Florida, and the Administrator for Primary Care Clinical Pharmacy Services for Kaiser Permanente in Denver, Colorado. Dr. Beall's research and practice interests include development of disease state management programs and pharmacoeconomic and pharmacotherapy analyses of various disease states such as migraine, depression, women's health issues, and preventative care.